EPO Aggressive Dosing May Increase Cardiovascular Risk – NEJM Studies
Two recently published studies may curtail aggressive elevation of hemoglobin levels with erythropoiesis-stimulating agents in anemia patients
Two recently published studies may curtail aggressive elevation of hemoglobin levels with erythropoiesis-stimulating agents in anemia patients